[New therapeutic agents in immunologic idiopathic thrombocytopenic purpura treatment: thrombopoietin receptor agonists]

Rev Med Interne. 2009 Oct;30(9 Suppl):13-5. doi: 10.1016/S0248-8663(09)72468-3.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Drugs, Investigational / therapeutic use*
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic / immunology
  • Purpura, Thrombocytopenic, Idiopathic / therapy*
  • Receptors, Fc / therapeutic use*
  • Receptors, Thrombopoietin / agonists*
  • Recombinant Fusion Proteins / therapeutic use*
  • Thrombopoietin / chemistry
  • Thrombopoietin / therapeutic use*

Substances

  • Drugs, Investigational
  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • MPL protein, human
  • Thrombopoietin
  • romiplostim